QT Imaging Holdings, Inc. (NASDAQ:QTI – Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 233,079 shares, a decrease of 53.0% from the May 14th total of 495,661 shares. Currently, 2.7% of the company’s stock are short sold. Based on an average daily volume of 54,372 shares, the days-to-cover ratio is presently 4.3 days.
Wall Street Analysts Forecast Growth
QTI has been the subject of several analyst reports. Wall Street Zen raised QT Imaging to a “hold” rating in a research note on Saturday, May 16th. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Report on QTI
QT Imaging Stock Performance
QT Imaging (NASDAQ:QTI – Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.11). The business had revenue of $6.53 million during the quarter, compared to the consensus estimate of $6.45 million. QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. As a group, research analysts anticipate that QT Imaging will post -0.59 earnings per share for the current year.
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Recommended Stories
- Five stocks we like better than QT Imaging
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
